Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer, KRAS G12C

Kathryn Arbour

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Assistant Attending Physician, Thoracic Oncology Service

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Kathryn Arbour is a thoracic oncologist at MSK investigating combination strategies for KRAS G12C-mutant NSCLC. She has led clinical and translational studies evaluating KRAS G12C inhibitors combined with MEK inhibitors and immunotherapy. Her research focuses on understanding how co-mutations like STK11 and KEAP1 influence therapeutic response and resistance in KRAS-mutant lung cancer.

Share:

🧪Research Fields 研究领域

KRAS G12C combination strategies
SHP2 KRAS co-targeting
immunotherapy plus KRAS inhibitor
STK11 co-mutation
thoracic oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kathryn Arbour 的研究动态

Follow Kathryn Arbour's research updates

留下邮箱,当我们发布与 Kathryn Arbour(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment